IL3 and acute myeloid leukemia: As a therapeutic aptamer, SS30 effectively inhibits the proliferation of acute myeloid leukemia (AML) cells by blocking the IL-3/CD123 signaling pathway, showing significant anti-tumor potential [191,192].